Dementia News and Research

Latest Dementia News and Research

New clinical research and imaging centre for Bristol

The University and United Bristol Healthcare Trust (UBHT) are joining forces to establish a new state-of-the-art Clinical Research and Imaging Centre (CRIC) at St Michael's Hospital on St Michael's Hill

21 May 2008

Rochester vaccine triggers immune response, prevents Alzheimer's

A vaccine created by University of Rochester Medical Center scientists prevents the development of Alzheimer's disease-like pathology in mice without causing inflammation or significant side effects.

19 May 2008

End-stage dementia patients deserve the same access to palliative care as people with cancer

There is an urgent need to improve end-of-life care for older people in the final stages of dementia, according to an international review published in the May issue of Journal of Clinical Nursing.

12 May 2008

Discovery of mechanism of action of antibiotic able to reduce neuronal cell death in brain

Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.

11 May 2008

Obesity may increase adults' risk for having dementia

Their analysis of published obesity and dementia prospective follow-up studies over the past two decades shows a consistent relationship between the two diseases. The results are published by The International Association for the Study of Obesity in the May, 2008 issue of Obesity Reviews.

7 May 2008

Obesity can increase dementia risk by up to 80 per cent - people who are underweight also face an elevated risk

Being obese can increase the risk of Alzheimer's Disease by as much as 80 per cent, according to a study in the May issue of the UK-based journal Obesity Reviews.

7 May 2008

Location technologies are improving NHS care

Some of the UK's leading experts in location technologies confirmed this week that applications such as RFID in hospitals are already improving the efficiency and quality of patient care. But they also warn that compatibility problems between hardware and software applications, and a lack of joined up thinking from technology companies mean that the NHS is not benefiting as much as it could.

6 May 2008

Ibuprofen found to reduce the risk of Alzheimer's

A large study by scientists in the U.S. has revealed that the long-term use of ibuprofen may reduce the risk of a person developing Alzheimer's disease.

6 May 2008

Short arms and legs could mean greater dementia risk

People with shorter arms and legs may be at a higher risk for developing dementia later in life compared to people with longer arms and legs, according to a study published in the May 6, 2008, bonus issue of Neurology, the medical journal of the American Academy of Neurology.

5 May 2008

Ibuprofen linked to lower risk of Alzheimer's

Long-term use of ibuprofen and other drugs commonly used for aches and pains was associated with a lower risk of Alzheimer's disease, according to a study published in the May 6, 2008, issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies have shown conflicting results, but this is the longest study of its kind.

5 May 2008

Dual treatment of incontinence and dementia associated with functional decline

Older nursing home residents who took medications for dementia and incontinence at the same time had a 50 percent faster decline in function than those who were being treated only for dementia, according to a study from researchers at Wake Forest University School of Medicine and colleagues.

1 May 2008

Alzheimer's disease risk differs between the sexes

The risks of developing Alzheimer's disease differ between the sexes, with stroke in men, and depression in women, critical factors, suggests research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry.

30 Apr 2008

Dual treatment of incontinence and dementia associated with functional decline

30 Apr 2008

Scientists discover way to increase metabolism for weight loss

Scientists from Melbourne's Howard Florey Institute have discovered a way to aid weight loss and reduce the likelihood of developing diabetes by manipulating fat cells to increase the body's metabolism.

28 Apr 2008

FDA approves Relistor for opioid-induced constipation - helps reduce effects of drugs like morphine on bowel function

The U.S. Food and Drug Administration today approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a continuous basis to help alleviate their pain.

24 Apr 2008

Pin1 is beneficial in Alzheimer's disease, detrimental to some forms of dementia

The most common form of dementia, Alzheimer's disease, and a relatively rare hereditary form of dementia, frontotemporal dementia with parkinsonism-17, share a common pathology: Both are the result of an overaccumulation of tau proteins, which form tangled lesions in the brain's neurons and eventually lead to the collapse of the brain cells responsible for memory.

22 Apr 2008

Discovery of molecular link between Alzheimer's disease and amyloid plaques

According to estimates there are 85,000 Alzheimer patients in our country and approximately 20,000 new cases every year. This spectacular increase is due to the increasing ageing population. Unfortunately it is still unclear precisely which ageing process forms the basis of this spectacular rise in the occurrence of the disease.

22 Apr 2008

An atomic view of protein behind hereditary cerebral amyloid angiopathy

For the first time, researchers have peered deeply at the atomic level into the protein that causes hereditary cerebral amyloid angiopathy (CAA) -- a disease thought to cause stroke and dementia.

22 Apr 2008

Drinking and smoking brings dementia on earlier

The latest research from the U.S. suggests that people who are heavy drinkers and smokers develop Alzheimer's disease six to seven years earlier than those who do not smoke or drink.

20 Apr 2008

Huperzine A for Alzheimer's disease

Existing evidence suggests that patients with Alzheimer’s disease who have taken Huperzine A have improved general cognitive function, global clinical status, functional performance and reduced behavioural disturbance compared to patients taking placebos.

17 Apr 2008